Amendment: SEC Form SC 13G/A filed by Agilent Technologies Inc.

11/12/24 1:27:37 PM ET

Biotechnology: Laboratory Analytical Instruments

Industrials

Get the next $A alert in real time by email

SC 13G/A 1 UnitedStates_13G__AgilentTec.txt 240.13d-102 Schedule 13G - Information to be included in statements filed pursuant to 240.13d-1(b), (c), and (d) and amendments thereto filed pursuant to 240.13d-2. Securities and Exchange Commission, Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. 12)* (Name of Issuer) Agilent Technologies Inc (Title of Class of Securities) Common Stock (CUSIP Number) 00846U101 (Date of Event Which Requires Filing of this Statement) September 30, 2024 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: X Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, an* d for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 ( Act ) or otherwise subject to the liabilities of that section of * the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 00846U101 (1) Names of reporting persons The Vanguard Group (2) Check the appropriate box if a member of a group (a) (see instructions) (b) X (3) SEC use only (4) Citizenship or place of organization Pennsylvania Number of shares beneficially owned by each reporting person with: (5) Sole voting power 0 (6) Shared voting power 357,698 (7) Sole dispositive power 32,149,743 (8) Shared dispositive power 1,296,783 (9) Aggregate amount beneficially owned by each reporting person 33,446,526 (10) Check if the aggregate amount in Row (9) excludes certain shares (see instructions) (11) Percent of class represented by amount in Row (9) 11.64% (12) Type of reporting person (see instructions) IA Item 1(a) Name of issuer: Agilent Technologies Inc Item 1(b) Address of issuer's principal executive offices: 5301 Stevens Creek Blvd Santa Clara, CA 95051 Items 2(a)-2(c). Name, Address Of principal business office, and Citizenship of* persons filing: The Vanguard Group - 23-1945930 100 Vanguard Blvd. Malvern, PA 19355 2(d) Title of class of securities: Common Stock 2(e) CUSIP Number: 00846U101 Item 3. This statement is being filed pursuant to Rule 13d-1. An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E). Item 4. Ownership As of the close of business on September 30, 2024: (a) Aggregate amount beneficially owned: 33,446,526 (b) Percent of class: 11.64% (c) Number of shares as to which person has: 1. The Vanguard Group (a) Amount beneficially owned: 33,446,526 (b) Percent of class: 11.64% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 357,698 (iii) Sole power to dispose or to direct the disposition of: 32,149,743 (iv) Shared power to dispose or to direct the disposition of: 1,296,783 Item 5.Ownership of 5 Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following . Item 6. Ownership of More than 5 Percent on Behalf of Another Person. The Vanguard Group, Inc.'s clients, including investment companies registered u* nder the Investment Company Act of 1940 and other managed accounts, have the ri* ght to receive or the power to direct the receipt of dividends from, or the pro* ceeds from the sale of, the securities reported herein. No one other person's interest in the securities reported herein is more than 5* %. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reporting on by the Parent Holding Company or Control Person. Not applicable Item 8. Identification and Classification of Members of the Group Not applicable Item 9. Notice of Dissolution of Group. Not applicable Item 10. Certifications By signing below I certify that, to the best of his/her knowledge and belief, t* he securities referred to above were not acquired and are not held for the pur* pose of or with the effect of changing or influencing the control of the issuer* of the securities and were not acquired and are not held in connection with or* as a participant in any transaction having that purpose or effect. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: November 12, 2024 THE VANGUARD GROUP By: /s/ Ashley Grim Name: Ashley Grim Title: Head of Global Fund Administration

Get the next $A alert in real time by email

Recent Analyst Ratings for

Date	Price Target	Rating	Analyst
8/28/2024	$157.00	Overweight	Wells Fargo
7/10/2024	$135.00 → $150.00	Neutral → Buy	Citigroup
6/27/2024		Outperform → Peer Perform	Wolfe Research
6/3/2024	$135.00	Hold	Jefferies
4/5/2024	$145.00 → $163.00	Hold → Buy	Stifel
12/13/2023	$140.00	Outperform	Wolfe Research
12/12/2023	$130.00 → $133.00	Buy → Neutral	BofA Securities
11/17/2023	$163.00 → $125.00	Buy → Neutral	UBS

More analyst ratings

Amendment: SEC Form SC 13G/A filed by Agilent Technologies Inc.

Chat with this insight

Recent Analyst Ratings for $A

$A Market Insights

Live Market Insights

(A) - Analyzing Agilent Technologies's Short Interest

Agilent Technologies To Acquire BIOVECTRA For $925M, Expanding End-To-End Biopharma Solutions For Accelerated Drug Discovery And Development

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,200 Today

$A Financials

Live finance-specific insights

Agilent Increases Cash Dividend to 24.8 Cents per Share

Agilent to Announce Fourth-Quarter Fiscal Year 2024 Financial Results on Nov. 25

Agilent Announces Cash Dividend of 23.6 Cents per Share

$A Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

$A SEC Filings

$A Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Senior Vice President Riemann Angelica was granted 1,045 shares and covered exercise/tax liability with 327 shares, increasing direct ownership by 5% to 15,896 units (SEC Form 4)

Sr. VP and CFO Mcmahon Robert W. was granted 7,835 shares and covered exercise/tax liability with 2,196 shares, increasing direct ownership by 4% to 166,115 units (SEC Form 4)

President and CEO Mcdonnell Padraig was granted 4,505 shares and covered exercise/tax liability with 1,506 shares, increasing direct ownership by 13% to 26,355 units (SEC Form 4)

Agilent Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

SEC Form 424B5 filed by Agilent Technologies Inc.

SEC Form 8-K filed by Agilent Technologies Inc.

SEC Form 4 filed by Gonsalves Rodney (Amendment)

Gonsalves Rodney bought $288 worth of shares (3 units at $111.09), increasing direct ownership by 0.01% to 24,222 units (SEC Form 4)

$A Press Releases

Fastest customizable press release news feed in the world

Agilent Increases Cash Dividend to 24.8 Cents per Share

Agilent 2024 Early Career Professor Award Presented to Adeyemi Adeleye

Agilent Announces the Innovative Mito-rOCR Assay Kit for Mitochondrial Research

$A Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by Agilent Technologies Inc.

SEC Form SC 13G filed by Agilent Technologies Inc.

SEC Form SC 13G filed by Agilent Technologies Inc.

$A Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Wells Fargo initiated coverage on Agilent with a new price target

Agilent upgraded by Citigroup with a new price target

Agilent downgraded by Wolfe Research

$A Leadership Updates

Live Leadership Updates

Agilent to Acquire North American CDMO BIOVECTRA

Politan Details Why a Truly Independent Board is Urgently Needed at Masimo in Order to Protect Shareholder Value and Realize the Company's Full Potential

Agilent Unveils the 8850 Gas Chromatograph: A Leap Forward in Analytical Excellence

Recent Analyst Ratings for
$A

$A
Market Insights

$A
Financials

$A
Insider Trading

$A
SEC Filings

$A
Insider Purchases

$A
Press Releases

$A
Large Ownership Changes

$A
Analyst Ratings

$A
Leadership Updates